ADROVAS-F
Type:
Tablet
Pack:
10x10
Packing:
Alu Alu
Category:
CARDIOLOGY
Price:
₹1,990.00
Contact Us to Purchase
Composition Details
Rosuvastatin 10mg + Fenofibrate 145mg
Description & Effects
ADROVAS-F is a dual-action lipid-lowering formulation that combines Rosuvastatin and Fenofibrate, two highly effective agents used to manage dyslipidemia and reduce the risk of cardiovascular events in patients with mixed hyperlipidemia or atherogenic lipid profiles.Rosuvastatin is a statin that works by inhibiting the enzyme HMG-CoA reductase, which plays a critical role in cholesterol synthesis in the liver. This results in a significant reduction in low-density lipoprotein (LDL or “bad” cholesterol) and total cholesterol, while also modestly increasing high-density lipoprotein (HDL or “good” cholesterol).
Fenofibrate, on the other hand, belongs to the fibrate class and works primarily by activating peroxisome proliferator-activated receptors (PPAR-α), which leads to enhanced breakdown and clearance of triglyceride-rich lipoproteins. It significantly reduces triglyceride levels and helps increase HDL cholesterol.
Together, the combination in ADROVAS-F provides a synergistic effect in improving the overall lipid profile—making it particularly beneficial for patients with mixed dyslipidemia, type 2 diabetes with high triglycerides, or metabolic syndrome. The dual mechanism also helps in reducing inflammation and preventing atherosclerotic plaque progression.
Regular monitoring of liver function and muscle enzymes is advised, as both agents can rarely cause hepatic or muscle-related side effects. The medication should be taken as prescribed, along with dietary and lifestyle modifications, for optimal cardiovascular protection.
